Valeant Pharmaceuticals International, Inc. (NYSE:VRX) shares are trading +0.147% thus far today and have traded in the range of 12.930 – 13.070 during the current session. In order to take a look at where the stock might headed longer term, we can also look at different sets of data. Sell-side research firms currently have a consensus one year price target of $14.880 on the stock according to First Call. This number can often vary from the Zacks or FactSet mean targets. The sell-side analysts are projecting earnings per share of $0.920 for the next fiscal quarter. For the current year, analysts are predicting earnings of $3.890 per share according to First Call.
Stock Technicals in Focus
In looking at where the stock is trading on a technical level, the stock is trading +20.131% away from its 50 day moving average of $10.779. Based on the most recent available data, the equity is -60.455% off of its 52-week high of $32.745 and +55.807% away from its 52-week low which is $8.311. In taking a look at the company’s valuation, the firm’s price to earnings ratio stands at N/A. This is a crucial indicator investors watch as higher ratios compared to peers, would suggest higher future earnings growth potential for the stock. The price to current year EPS estimates from research analysts currently stands at 3.567. In looking further ahead, potential investors should note that the company’s price to next year’s EPS estimates is 3.329.
Today, the stock opened at $12.930 and the last bid at the time of writing stood at $12.949. During the session thus far, the equity dipped down to $12.930 and touched $13.070 as the high point. Valeant Pharmaceuticals Interna has a market cap of 4.51B and has seen an average daily volume of 25143000 over the past three months.
Wall Street sell-side research analysts covering The Coca-Cola Co (NYSE:KO) shares have recently provided various price target projections on where the stock might be going. According to them, the stock is expected to reach $45.375 on a consensus level within the next year, according to Zacks. The most bullish estimate sees the stock reaching $50 while the most conservative estimate stand at $42.
Zacks also gives an average broker rating based on the sell-side recommendations from the analysts who cover The Coca-Cola Co. They give the company shares an ABR of 2.67. This is based on the 8 analysts taken into consideration by Zacks.
Earnings Estimates for The Coca-Cola Co (NYSE:KO)
Currently, Wall Street is projecting that the firm will post $0.57 earnings per share. This consensus number is also derived from Zacks. For the most recent period which ended on 2017-03-31, The Coca-Cola Co's EPS was reported as $0.43. This created a “surprise factor” -2.27% due to being $-0.01 apart from what Wall Street predicted. When actual numbers differ greatly from the consensus expectations, sharp movement in the stock price can often be seen in the hours or days following the report.
Investors will mark their calendars for 2017-07-26, the date when The Coca-Cola Co (NYSE:KO) are expected to release their quarterly results.